These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16098147)

  • 1. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
    Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
    Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
    Kim EJ; Park JS; Um SJ
    Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of Smad4 transcriptional activity by SUMO modification.
    Long J; Wang G; He D; Liu F
    Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
    Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
    Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
    J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
    Tian S; Poukka H; Palvimo JJ; Jänne OA
    Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum response factor is modulated by the SUMO-1 conjugation system.
    Matsuzaki K; Minami T; Tojo M; Honda Y; Uchimura Y; Saitoh H; Yasuda H; Nagahiro S; Saya H; Nakao M
    Biochem Biophys Res Commun; 2003 Jun; 306(1):32-8. PubMed ID: 12788062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
    Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
    Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity.
    Kalita K; Kharebava G; Zheng JJ; Hetman M
    J Neurosci; 2006 Sep; 26(39):10020-32. PubMed ID: 17005865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.
    Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH
    Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
    Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
    Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO represses transcriptional activity of the Drosophila SoxNeuro and human Sox3 central nervous system-specific transcription factors.
    Savare J; Bonneaud N; Girard F
    Mol Biol Cell; 2005 Jun; 16(6):2660-9. PubMed ID: 15788563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
    Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
    Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.